The SAFE study: a landmark trial of the safety of albumin in intensive care.
High-quality primary evidence from an Australian and New Zealand study provides a definitive answer.
Finfer
Simon R
SR
Boyce
Neil W
NW
Norton
Robyn N
RN
D000418:Albumins / Q000009:adverse effects*; D001315:Australia; D003422:Critical Care; D017052:Hospital Mortality; D006801:Humans; D007362:Intensive Care Units; D007902:Length of Stay; D009520:New Zealand; D016032:Randomized Controlled Trials as Topic
D000418:Albumins